- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01973933
Clinical Trial to Investigate the Pharmacokinetic/Pharmacodynamic Drug-Drug Interaction of Pyrimethamine and Metformin IR
October 27, 2013 updated by: Jae Yong Chung, Seoul National University Hospital
A Open-label, Single Sequence Clinical Trial to Investigate the Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Pyrimethamine and Metformin IR After Oral Administration in Healthy Male Volunteers
This study aims to investigate the pharmacokinetic/pharmacodynamic drug-drug interaction of pyrimethamine and metformin IR after oral administration in healthy male volunteers.
Study Overview
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Seoul National University Bundang Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- healthy male subject aged 20 to 45 at screening A body weight in the range of 50 kg (inclusive)
- 100 kg (inclusive) with ideal body weight range of +- 25% subjects who decide to participate voluntarily and write a informed consent form
Exclusion Criteria:
- subjects who have clinically significant disease of cardiovascular, respiratory, renal, endocrinological, hematological, gastrointestinal, neurological(central nervous system), psychiatric disorders or malignant tumor
- Subject judged not eligible for study participation by investigator.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Metformin and Pyrimethamine
Metformin 750mg(D1), Metformin 500mg(D2)/Metformin 750mg+Pyrimethamine 50mg(D7), Metformin 500mg+Pyrimethamine 50mg(D8)
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
AUC(area under the plasma concentration-time curve)
Time Frame: Predose and 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 10, 12h postdose
|
AUC(area under the plasma concentration-time curve), Cmax(maximum plasma concentration), t1/2
|
Predose and 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 10, 12h postdose
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
AUG(total area under the serum concentration-time curve for glucose)
Time Frame: predose and 15, 30, 45, 60, 90, 120, 150, 180min oral glucose tolerance test
|
AUG (total area under the serum concentration-time curve for glucose) Gmax(maximum serum glucose concentration)
|
predose and 15, 30, 45, 60, 90, 120, 150, 180min oral glucose tolerance test
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jae-Yong Chung, MD, PhD, Department of Clinical Pharmacology and Therapeutics, Seoul National University Bundang Hospital, Seoul, Korea
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2013
Primary Completion (Actual)
August 1, 2013
Study Registration Dates
First Submitted
October 27, 2013
First Submitted That Met QC Criteria
October 27, 2013
First Posted (Estimate)
November 1, 2013
Study Record Updates
Last Update Posted (Estimate)
November 1, 2013
Last Update Submitted That Met QC Criteria
October 27, 2013
Last Verified
October 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MPI02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Metformin and Pyrimethamine
-
London School of Hygiene and Tropical MedicineMinistry of Health, GhanaCompleted
-
University of MelbourneUniversity of Barcelona; Papua New Guinea Institute of Medical Research; The... and other collaboratorsCompletedSexually Transmitted Infections | Malaria in Pregnancy | AnaemiaPapua New Guinea
-
Walter Reed Army Institute of Research (WRAIR)CompletedMalaria, Falciparum | Malaria, VivaxPeru
-
Emzor Pharmaceutical Industries LimitedNot yet recruiting
-
Tampere UniversityAcademy of Finland; Foundation for Paediatric Research, FinlandActive, not recruitingSexually Transmitted Diseases | Pregnancy | Preterm Birth | MalariaMalawi
-
London School of Hygiene and Tropical MedicineCheikh Anta Diop University, SenegalCompleted
-
London School of Hygiene and Tropical MedicineMalaria Research and Training Center, Bamako, Mali; Institut de Recherche en...CompletedMalaria | Respiratory InfectionsBurkina Faso, Mali
-
London School of Hygiene and Tropical MedicineTerminated
-
University of Cape TownWorld Health Organization; Medical Research Council, South Africa; Global FundCompleted
-
London School of Hygiene and Tropical MedicineMedical Research Council Unit, The GambiaCompletedAsymptomatic P.Falciparum MalariaGambia